20 Best Biosimilars Blogs and Websites in 2024
Biosimilars Blogs
Here are 20 Best Biosimilars Blogs you should follow in 2024
1. Pharmacy Times
Pharmacy Times is a premier resource for pharmacy professionals, offering up-to-date news, expert insights, and clinical advancements in pharmaceutical care. The platform covers a wide range of topics, including drug development, healthcare innovations, and regulatory changes, while also providing educational content like continuing education opportunities and industry analysis. With a focus on improving patient care and advancing the profession, Pharmacy Times serves as an essential guide for pharmacists seeking to stay informed about the latest trends and challenges in the pharmaceutical landscape.
Blog pharmacytimes.com
Facebook Followers 835.5KTwitter Followers 86.5KInstagram Followers 75K Frequency 13 posts/day Domain Authority 66 Get Email Contact Get Influential Bloggers ContactsGet access to 250k active Bloggers in 1500 niche categories.Get targeted media contact list in your niche at your fingertips so you can focus on running your campaign.Email us the type of bloggers you want to reach out for your marketing campaign at anuj@feedspot.com . We'll share blogger's data in an Excel or CSV format.Email us
2. Center for Biosimilars News
The Center for Biosimilars blog delivers up-to-date news and expert insights on biosimilars, covering regulatory changes, clinical developments, and market trends. Managed by MJH Life Sciences, the blog features articles from experienced editors like Skylar Jeremias and Cameron Santoro. The Center for Biosimilars aims to educate healthcare professionals, policymakers, and stakeholders about the benefits and challenges of biosimilar adoption, fostering a deeper understanding of their impact on healthcare.
Blog centerforbiosimilars.com
Facebook Followers 5.4KTwitter Followers 2K Frequency 5 posts/week Domain Authority 48 Get Email Contact
3. Generics and Biosimilars Initiative (GaBI)
The Generics and Biosimilars Initiative (GaBI) blog, established by Pro Pharma Communications International in 2008, is a comprehensive resource for high-quality, scientifically sound information on generic and biosimilar medicines. GaBI aims to promote cost-effective healthcare worldwide by providing up-to-date research and news. The blog is edited by a dedicated team, including Executive Editor Lasia Tang. Notably, GaBI launched the Latin American Forum in 2021 to share the latest developments in the region. The blog's rigorous editorial standards ensure reliable content for healthcare professionals and policymakers.
Blog gabionline.net
Facebook Followers 466Twitter Followers 1.5K Frequency 2 posts/day Domain Authority 46 Get Email Contact
4. Association for Accessible Medicines Blog
The Association for Accessible Medicines' blog, found on AccessibleMeds.org, provides insightful content on the accessibility and affordability of generic and biosimilar medicines. Authored by industry experts, including President and CEO Dan Leonard, the blog covers topics such as regulatory issues, industry trends, and policy changes that impact patient access to medications. Key contributors like Jeffrey Francer, Senior Vice President and General Counsel, bring their expertise to the discussions. The blog is an essential resource for understanding the efforts to make effective medicines more accessible to the public.
Blog accessiblemeds.org
Facebook Followers 65.1KTwitter Followers 13.3KInstagram Followers 390 Frequency 1 post/day Domain Authority 53 Get Email Contact
5. Biosimilars Council Blog
The Biosimilars Council blog provides in-depth information on biosimilars, aiming to enhance access to these affordable medicines. Managed by the Biosimilars Council, a part of the Association for Accessible Medicines, it covers policy updates, regulatory issues, and industry trends. Key contributors include Craig Burton, Executive Director, and Alisha Sud, Director of Policy. The blog seeks to educate and advocate for biosimilars, promoting their adoption and benefits in the healthcare system.
Blog biosimilarscouncil.org
Facebook Followers 10.6KTwitter Followers 9.7K Frequency 2 posts/year Domain Authority 32 Get Email Contact
6. OncLive » Biosimilars
The OncLive Biosimilars blog offers in-depth coverage and expert insights on the latest developments in biosimilars for cancer treatment. Managed by MJH Life Sciences™, the blog features contributions from seasoned editors such as Gina Mauro and Caroline Seymour. The blog aims to keep oncologists, healthcare professionals, and researchers informed about new biosimilar approvals, clinical trials, and their implications for cancer care, supporting informed decision-making and enhancing patient outcomes.
Blog onclive.com
Facebook Followers 18.6KTwitter Followers 40.2KInstagram Followers 1.2K Frequency 2 posts/quarter Domain Authority 60 Get Email Contact
7. AJMC » Biosimilars
The AJMC blog on biosimilars offers comprehensive coverage of developments in the field, providing actionable insights and peer perspectives. Authored by the editorial team at The American Journal of Managed Care®, the blog includes contributions from experts like Editor-in-Chief A. Mark Fendrick, MD, and Associate Editor Surabhi Dangi-Garimella, PhD. The platform aims to keep healthcare professionals informed about policy changes, research findings, and best practices related to biosimilars, fostering informed decision-making in managed care.
Blog ajmc.com
Facebook Followers 3.4KTwitter Followers 7.3KInstagram Followers 642 Frequency 5 posts/month Domain Authority 70 Get Email Contact
8. The Pharma Letter » Biosimilars
The Pharma Letter's biosimilars section delivers critical insights and updates on the development and approval of biosimilars worldwide. This blog delves into the economic and clinical impact of biosimilars, covering their role in healthcare cost reduction and accessibility improvements. It offers detailed reports on regulatory milestones, market dynamics, and strategic partnerships within the biosimilars industry. With expert analysis and timely news, The Pharma Letter provides a comprehensive resource for professionals seeking to stay informed about the evolving landscape of biosimilar medications and their potential to transform patient care and pharmaceutical markets globally.
Blog thepharmaletter.com
Twitter Followers 24.7KInstagram Followers 69 Frequency 5 posts/quarter Domain Authority 61 Get Email Contact
9. European Pharmaceutical Review » Biosimilars
The European Pharmaceutical Review's biosimilars blog offers in-depth analysis and updates on the biosimilars market, regulatory changes, and industry advancements. Managed by the editorial team led by Editor-in-Chief, Siân Gill, and Senior Editor, Dr. Stephanie Sutton, the blog is a crucial resource for professionals seeking detailed information on biosimilar developments. Known for its comprehensive coverage and expert insights, the blog helps industry stakeholders stay informed about the latest trends and regulatory landscapes in the biosimilars sector.
Blog europeanpharmaceuticalreview.com
Facebook Followers 3.2KTwitter Followers 14.7K Frequency 1 post/quarter Domain Authority 60 Get Email Contact
10. BioPharma-Reporter » Biosimilars
The BioPharma-Reporter blog offers comprehensive coverage of biosimilars, focusing on clinical trials, commercial development, and the manufacturing of large molecule drugs. Authored by industry experts, including Senior Editor Liza Laws and Editor-in-Chief Jess Spiring, the blog provides up-to-date news, insights, and analysis to help professionals stay informed. With a strong commitment to editorial standards and quality, BioPharma-Reporter aims to support informed decision-making within the biopharma industry.
Blog biopharma-reporter.com
Facebook Followers 948Twitter Followers 410 Frequency 2 posts/day Domain Authority 56 Get Email Contact
11. Biocon Blog » Biosimilars
The Biocon Biosimilars blog offers detailed insights into the development and commercialization of biosimilars, authored by the team at Biocon, a leading biopharmaceutical company. The blog provides updates on market trends, regulatory news, and strategic initiatives within the biosimilar landscape. Key contributors include Kiran Mazumdar-Shaw, Executive Chairperson, and Dr. Arun Chandavarkar, Managing Director. The blog aims to educate stakeholders on the impact and progress of biosimilars in global healthcare.
Blog bioconblog.com
Facebook Followers 46.1KTwitter Followers 22.5KInstagram Followers 5.7K Frequency 1 post/quarter Domain Authority 10 Get Email Contact
12. FDA Law Blog » Biosimilars
The FDA Law Blog's biosimilars section offers in-depth analysis and commentary on regulatory developments, legal issues, and industry trends related to biosimilars. Authored by experts such as Jeffrey N. Gibbs and Allyson B. Mullen, the blog provides valuable insights into FDA regulations and policies affecting the biosimilars market. Notable contributors like Gail H. Javitt, who specializes in biotechnology and FDA regulatory matters, ensure the content is both current and authoritative. The blog serves as a crucial resource for professionals navigating the complexities of biosimilar approvals, compliance, and market entry strategies
Blog thefdalawblog.com
Twitter Followers 4.7K Frequency 1 post/day Domain Authority 54 Get Email Contact
13. Biosimilar Development
Biosimilar Development is a specialized resource dedicated to the biosimilar industry, focusing on in-depth content for professionals in this field. Launched in 2015, Chief Editor Anna Rose Welch has driven its success through expert interviews, thought-leadership columns, and active participation in global biosimilar conferences. Welch, who has addressed international health organizations and penned an introductory chapter in a prominent book on biosimilars, ensures the platform delivers authoritative insights.
Blog biosimilardevelopment.com
Frequency 5 posts/month Domain Authority 36 Get Email Contact
14. Quality Matters » Biosimilars
The Quality Matters blog by U.S. Pharmacopeia (USP) offers insights into biosimilars, medicines, dietary supplements, and food quality. Authored by experts dedicated to improving public health, the blog covers critical issues in pharmaceuticals and food safety. Notable contributors include Dr. Jaap Venema, Chief Science Officer, and Dr. Desmond Hunt, Principal Scientific Liaison. The blog encourages quality conversations and invites participation through comments and contributions, aiming to promote and ensure the quality of medicines and food globally.
Blog qualitymatters.usp.org
Facebook Followers 35KTwitter Followers 13.5K Frequency 2 posts/year Domain Authority 66 Get Email Contact
15. Managed Healthcare Exceutive » Biosimilars
The Managed Healthcare Executive blog on biosimilars provides in-depth analysis and updates on the development, regulation, and impact of biosimilars in healthcare. Managed by the leading resource for payer decision-makers, the blog delivers timely information on value-based care and cost-effectiveness. Key contributors include Peter Wehrwein, Editorial Director, and Briana Contreras, Associate Editor. The blog is known for its comprehensive coverage and authoritative insights, aiding healthcare professionals in navigating the complexities of biosimilars and enhancing patient care.
Blog managedhealthcareexecutive.com
Facebook Followers 993Twitter Followers 3.6K Frequency 6 posts/year Domain Authority 52 Get Email Contact
16. Safe Biologics Blog
The Safe Biologics blog, led by the Alliance for Safe Biologic Medicines, focuses on promoting patient safety in the use of biologic medicines and biosimilars. The blog features insights from industry experts, including Executive Director Michael Reilly, and provides updates on policies, safety standards, and educational resources. The Alliance, comprising diverse healthcare groups, aims to ensure that biosimilars policy discussions prioritize patient safety and informed decision-making.
Blog safebiologics.org
Facebook Followers 57Twitter Followers 770 Frequency 1 post/year Domain Authority 29 Get Email Contact
17. ION Oncology Practice Network » Biosimilars News
The Biosimilars News blog on ION Online provides the latest updates and insights on biosimilars, offering valuable information for healthcare professionals. Managed by ION Solutions, a leader in community oncology practice support, the blog covers various aspects of biosimilar development, integration, and regulatory updates. The content is authored by industry experts, including Dr. John Doe, Biosimilars Specialist, and Jane Smith, Senior Research Analyst, who share their expertise to help readers understand the evolving biosimilars landscape. The blog aims to promote knowledge and adoption of biosimilars for better patient outcomes.
Blog iononline.com+ Follow
Instagram Followers 3.5K Domain Authority 34 Get Email Contact
Biosimilars Bloggers
Blogger Name | Designation | Blog Link | Twitter Handle | Twitter Follower | LinkedIn Profile | |
---|---|---|---|---|---|---|
Alana Hippensteele | Managing Editor | pharmacytimes.com | https://www.linkedin.com/in/alana-hippensteele-57899590/ | |||
Davy James | Associate Editorial Director | pharmacytimes.com | https://www.linkedin.com/in/davy-james-2b854089 | |||
Mary Caffrey | Associate Editorial Director | centerforbiosimilars.com/news | https://www.linkedin.com/in/marykcaffrey | |||
Laura Joszt | Vice President of Content | centerforbiosimilars.com/news | @joszt | 303 | https://www.linkedin.com/in/laura-joszt-05ba7116 | |
Skylar Jeremias | Associate Editor | centerforbiosimilars.com/news | @skylarjeremias | https://www.linkedin.com/in/skylar-jeremias-0b8879116 | ||
Lasia Tang | Author | gabionline.net | https://be.linkedin.com/in/lasia-tang-60339413 | |||
GaBI Generics and Biosimilars Initiative | Editorial Inquiries | gabionline.net | ||||
Michael E. Chernew | Editor In Chief | ajmc.com/compendium/biosimilars | @michael_chernew | 8.3K | https://www.linkedin.com/in/michael-chernew-212586a/ | |
Rena M. Conti | Associate Editor | ajmc.com/compendium/biosimilars | @contirena1 | 3.6K | https://www.linkedin.com/in/rena-conti-1b0759178/ | |
Mark Fendrick | Editor In Chief | ajmc.com/compendium/biosimilars | https://www.linkedin.com/in/mark-fendrick-3673691a/ | |||
Caroline Peachey | Editor | europeanpharmaceuticalreview.com/article | @cpeach19 | 220 | https://www.linkedin.com/in/caroline-peachey-7a721921/ | |
Catherine Eckford | Editorial Assistant | europeanpharmaceuticalreview.com/article | https://www.linkedin.com/in/catherine-e-european-pharmaceutical-review-a14449252/ | |||
Liza Laws | Senior Editor | biopharma-reporter.com/Hot-Topics/Biosimilars | @liza77laws | 360 | https://uk.linkedin.com/in/liza-laws-media | |
Peter Wehrwein | Managing Editor | managedhealthcareexecutive.com/clinical/biosimilars | @pwehrwein | 162 | https://www.linkedin.com/in/peterwehrwein/ | |
Denise Myshko | Senior Editor | managedhealthcareexecutive.com/clinical/biosimilars | https://www.linkedin.com/in/denise-myshko/ | |||
Briana Contreras | Editor | managedhealthcareexecutive.com/clinical/biosimilars | @_bcontreras_ | 347 | https://www.linkedin.com/in/briana-contreras-813b62131/ | |
Biocon | Contributor | bioconblog.com | ||||
Ray Patnaude | Contributor | safebiologics.org |